Patent Assignment
Reel/Frame 045061/0645
Merger
Recorded: 2017-11-14
Pages: 24
Assignor
ALFA WASSERMANN S.P.A.
Executed: 2017-08-01
Assignee
ALFASIGMA S.P.A.
VIALE SARCA N. 223,, MILANO (MI),, ITALY
Covered Properties
(46)
Pharamaceutical Compositions Containing Calcitonin in a Spray Dosing Feeder for Intranasal Administration
Patent:
6,149,893 →
Application:
09/259,728 →
Use of Sulodexide and of the Medicines Containing It in the Treatment of the Diabetic Retinopathy
Patent:
6,080,732 →
Application:
09/266,385 →
Methods and Compositions Using Sulodexide for the Treatment of Diabetic Nephropathy
Bifidobacteria and Preparations Containing Them
Polymorphous Forms of Rifaximin, Processes for Their Production and Use Thereof in Medicinal Preparations
Polymorphous Forms of Rifaximin, Processes for Their Production and Use Thereof in the Medicinal Preparations
Gastroresistant Pharmaceutical Formulations Containing Rifaximin
Use of Polymorphic Forms of Rifaximin for Medical Preparations
Polymorphic Forms Alpha, Beta and Gamma of Rifaximin
Processes for the Production of Polymorphic Forms of Rifaximin
Pharmaceutical Compositions Comprising Polymorphic Forms Alpha, Beta, and Gamma of Rifaximin
Use of Polyols to Obtain Stable Polymorphous Forms of Rifaximin
Rifamycin Derivatives
Polymorphic Forms Alpha, Beta, and Gamma of Rifaximin
Polymorphic Forms Alpha, Beta and Gamma of Rifaximin
Processes for the Production of Polymorphic Forms of Rifaximin
Pharmaceutical Compositions Comprising Polymorphic Forms Alpha, Beta, and Gamma of Rifaximin
Use of Polymorphic Forms of Rifaximin for Medical Preparations
Agent for Preventing and/or Treating Functional Gastrointestinal Disorder
Compositions for Bowel Cleansing and Use Thereof
Polymorphous Forms of Rifaximin, Processes for Their Production and Use Thereof in the Medicinal Preparations
Use of Polyols to Obtain Stable Polymorphous Forms of Rifaximin
Pharmaceutical Compositions Comprising Rifaximin, Processes For Their Preparation And Their Use In The Treatment Of Vaginal Infections
Rifaximin Powder, Process for Preparing the Same and Controlled Release Compositions Containing Said Rifaximin Useful for Obtaining a Long-Lasting Effect
Sulodexide for Use in the Treatment of Pathologies Wherein Metalloproteinases Are Involved
Pharmaceutical Compositions Comprising Polymorphic Forms Alpha, Beta, and Gamma of Rifaximin
Polymorphic Forms Alpha, Beta and Gamma of Rifaximin
Rifamycin Derivatives
Pharmaceutical Compositions Comprising Rifaximin and Amino acids, Preparation Methods and Use Thereof
Polymorphous Forms of Rifaximin, Processes for Their Production and Use Thereof in the Medicinal Preparations
Gastroresistant Pharmaceutical Formulations Containing Rifaximin
Gastroresistant Pharmaceutical Formulations Containing Rifaximin
Application:
14/097,222 →
Publication:
US 2014/0186450
Nsaid Administration and Related Compositions, Methods and Systems
Application:
14/251,516 →
Publication:
US 2014/0308350
Rifaximin Powder, Process for Preparing the Same and Controlled Release Compositions Containing Said Rifaximin Useful for Obtaining a Long-Lasting Effect
Polymorphous Forms of Rifaximin, Processes for Their Production and Use Thereof in the Medicinal Preparations
Rifaximin Derivative and Uses Thereof
Method of Treating Gerd with Alpha and Beta Galactosidases
Rifaximin Derivative and Uses Thereof
Pharmaceutical Formulations Containing Rifaximin, Processes for Their Obtainment and Method of Treating Intestinal Disease
Application:
15/130,324 →
Publication:
US 2017/0071916
Use of Polyols to Obtain Stable Polymorphous Forms of Rifaximin
Rifaximin Derivative and Uses Thereof
Pharmaceutical or Nutritional Compositions Containing Alpha-Galactosidase and Beta-Galactosidase
Application:
15/194,431 →
Publication:
US 2016/0303206
Pharmaceutical Compositions Comprising Polymorphic Forms Alpha, Beta, and Gamma of Rifaximin
Application:
15/255,047 →
Publication:
US 2017/0210757
Polymorphic Forms Alpha, Beta and Gamma of Rifaximin
Application:
15/255,651 →
Publication:
US 2017/0210758
New Solvated Crystal Form of Rifaximin, Production, Compositions and Uses Thereof
Therapeutic and Nutritional Compositions for Functional Gastrointestinal Disorders
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 4, 2014
From: ZAMBONI, VILLIAM
To: ALFA WASSERMANN S.P.A.
Reel/Frame 032610/0805 →
Assignment of Assignor's Interest
Apr 4, 2014
From: PANTALEO, MARIA ROSARIA
To: ALFA WASSERMANN S.P.A.
Reel/Frame 032610/0801 →
Assignment of Assignor's Interest
Apr 4, 2014
From: PALAZZINI, ERNESTO
To: ALFA WASSERMANN S.P.A.
Reel/Frame 032610/0797 →
Assignment of Assignor's Interest
Apr 4, 2014
From: VISCOMI, GIUSEPPE C.
To: ALFA WASSERMANN S.P.A.
Reel/Frame 032610/0784 →
Assignment of Assignor's Interest
Apr 29, 2015
From: ALFA WASSERMANN, INC.
To: ALFA WASSERMANN S.P.A.
Reel/Frame 035532/0728 →
Assignment of Assignor's Interest
Nov 3, 2015
From: SEVERINI, DENIS
To: ALFA WASSERMANN S.P.A.
Reel/Frame 036952/0270 →
Change of Address
Oct 15, 2019
From: ALFASIGMA S.P.A.
To: ALFASIGMA S.P.A.
Reel/Frame 050727/0652 →
Assignment of Assignor's Interest
Jun 2, 2020
From: VISCOMI, GIUSEPPE C.; CAMPANA, MANUELA; CONFORTINI, DONATELLA; BARBANTI, MIRIAM
To: ALFA WASSERMANN S.P.A.
Reel/Frame 052816/0483 →
Assignment of Assignor's Interest
Jun 25, 2020
From: VISCOMI, GIUSEPPE CLAUDIO; CAMPANA, MANUELA; BRAGA, DARIO; CONFORTINI, DONATELLA
To: ALFA WASSERMANN S.P.A.
Reel/Frame 053044/0234 →
Assignment of Assignor's Interest
Jun 25, 2020
From: VISCOMI, GIUSEPPE CLAUDIO; CAMPANA, MANUELA; BRAGA, DARIO; CONFORTINI, DONATELLA
To: ALFA WASSERMANN S.P.A.
Reel/Frame 053038/0255 →
Assignment of Assignor's Interest
Jul 1, 2020
From: VISCOMI, GIUSEPPE CLAUDIO; CAMPANA, MANUELA; BRAGA, DARIO; CONFORTINI, DONATELLA
To: ALFA WASSERMANN S.P.A.
Reel/Frame 053103/0918 →
Assignment of Assignor's Interest
Jul 1, 2020
From: VISCOMI, GIUSEPPE CLAUDIO; CAMPANA, MANUELA; BRAGA, DARIO; CONFORTINI, DONATELLA
To: ALFA WASSERMANN S.P.A.
Reel/Frame 053102/0196 →